Treatment with Bufalin, known for its ability to inhibit SRC‐1 expression, significantly reduced MMP‐9 expression and effectively inhibited HCC metastasis both in vitro and in vivo. This evidence concerns the gene MMP9 and hepatocellular carcinoma.